Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium-Reference-Cited by-同舟云学术

Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

Published:2024-08-08 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Marcos-Villar Laura¹²^ORCID,Perdiguero Beatriz¹²^ORCID,López-Bravo María³^ORCID,Zamora Carmen¹^ORCID,Sin Laura¹²^ORCID,Álvarez Enrique¹^ORCID,Sorzano Carlos Óscar S.⁴^ORCID,Sánchez-Cordón Pedro J.⁵^ORCID,Casasnovas José M.⁶^ORCID,Astorgano David¹^ORCID,García-Arriaza Juan¹²^ORCID,Anthiya Shubaash⁷^ORCID,Borrajo Mireya L.⁷^ORCID,Lou Gustavo⁷^ORCID,Cuesta Belén⁷,Franceschini Lorenzo⁸^ORCID,Gelpí Josep L.⁹¹⁰^ORCID,Thielemans Kris⁸^ORCID,Sisteré-Oró Marta¹¹,Meyerhans Andreas¹¹¹²^ORCID,García Felipe¹³¹⁴^ORCID,Esteban Ignasi¹⁴,López-Bigas Núria¹²¹⁵¹⁶^ORCID,Plana Montserrat²¹⁴^ORCID,Alonso María J.⁷¹⁷^ORCID,Esteban Mariano¹,Gómez Carmen Elena¹²^ORCID

Affiliation:

1. Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

3. Department of Microbial Biotechnology, CNB, CSIC, Madrid, Spain

4. Biocomputing Unit and Computational Genomics, CNB, CSIC, Madrid, Spain

5. Veterinary Pathology Department, Centro de Investigación en Sanidad Animal (CISA), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), CSIC, Madrid, Spain

6. Department of Macromolecular Structures, CNB, CSIC, Madrid, Spain

7. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

8. Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium

9. Barcelona Supercomputing Center (BSC), Barcelona, Spain

10. Department of Biochemistry and Molecular Biomedicine, University of Barcelona (UB), Barcelona, Spain

11. Infection Biology Laboratory, Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain

12. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

13. Infectious Diseases Department, Hospital Clínic, UB, Barcelona, Spain

14. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, UB, Barcelona, Spain

15. Institute for Research in Biomedicine (IRB), Barcelona, Spain

16. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain

17. Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain

Funder

Spanish State Research Agency

Instituto de Salud Carlos III

Fondo Europeo para el Desarrollo Regional (FEDER) the CERCA Programme/Generalitat de Catalunya

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2387906

Reference54 articles.

1. COVID-19 Vaccines

2. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

3. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

4. SARS-CoV-2 Variants and Vaccines

5. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity